Are you suggesting insider trading (highly doubt it, the FDA clinical trials are double blind and just occurred)......more likely he needed the cash and he has plenty still left.
Ann: Change of Director's Interest Notice, page-6
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #